243 related articles for article (PubMed ID: 34475205)
1. AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase.
Yoshihama Y; LaBella KA; Kim E; Bertolet L; Colic M; Li J; Shang X; Wu CJ; Spring DJ; Wang YA; Hart T; DePinho RA
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34475205
[TBL] [Abstract][Full Text] [Related]
2. A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR.
Wolf SS; Patchev VK; Obendorf M
Arch Biochem Biophys; 2007 Apr; 460(1):56-66. PubMed ID: 17353003
[TBL] [Abstract][Full Text] [Related]
3. Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia.
Izaguirre-Carbonell J; Christiansen L; Burns R; Schmitz J; Li C; Mokry RL; Bluemn T; Zheng Y; Shen J; Carlson KS; Rao S; Wang D; Zhu N
Blood Adv; 2019 May; 3(9):1499-1511. PubMed ID: 31076406
[TBL] [Abstract][Full Text] [Related]
4. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
Zhang J; Li Q; Zhang S; Xu Q; Wang T
Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
[TBL] [Abstract][Full Text] [Related]
5. Histone demethylase JMJD1C promotes the polarization of M1 macrophages to prevent glioma by upregulating miR-302a.
Zhong C; Tao B; Yang F; Xia K; Yang X; Chen L; Peng T; Xia X; Li X; Peng L
Clin Transl Med; 2021 Sep; 11(9):e424. PubMed ID: 34586733
[TBL] [Abstract][Full Text] [Related]
6. Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer.
Lee KH; Hong S; Kang M; Jeong CW; Ku JH; Kim HH; Kwak C
Int J Cancer; 2018 Dec; 143(11):2849-2861. PubMed ID: 30183076
[TBL] [Abstract][Full Text] [Related]
7. Comparative integromics on JMJD1C gene encoding histone demethylase: conserved POU5F1 binding site elucidating mechanism of JMJD1C expression in undifferentiated ES cells and diffuse-type gastric cancer.
Katoh M; Katoh M
Int J Oncol; 2007 Jul; 31(1):219-23. PubMed ID: 17549425
[TBL] [Abstract][Full Text] [Related]
8. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II.
Zhang S; Lu Y; Jiang C
J Recept Signal Transduct Res; 2020 Aug; 40(4):339-347. PubMed ID: 32122211
[TBL] [Abstract][Full Text] [Related]
10. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D.
Shin S; Janknecht R
Biochem Biophys Res Commun; 2007 Aug; 359(3):742-6. PubMed ID: 17555712
[TBL] [Abstract][Full Text] [Related]
11. JMJD1C-regulated lipid synthesis contributes to the maintenance of
Qi D; Wang J; Zhao Y; Yang Y; Wang Y; Wang H; Wang L; Wang Z; Xu X; Hu Z
Leuk Lymphoma; 2022 Sep; 63(9):2149-2160. PubMed ID: 35468015
[No Abstract] [Full Text] [Related]
12. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J
Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835
[TBL] [Abstract][Full Text] [Related]
13. JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.
Lynch JR; Salik B; Connerty P; Vick B; Leung H; Pijning A; Jeremias I; Spiekermann K; Trahair T; Liu T; Haber M; Norris MD; Woo AJ; Hogg P; Wang J; Wang JY
Leukemia; 2019 Jun; 33(6):1400-1410. PubMed ID: 30622285
[TBL] [Abstract][Full Text] [Related]
14. JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors.
Chen M; Zhu N; Liu X; Laurent B; Tang Z; Eng R; Shi Y; Armstrong SA; Roeder RG
Genes Dev; 2015 Oct; 29(20):2123-39. PubMed ID: 26494788
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis.
Viscarra JA; Wang Y; Nguyen HP; Choi YG; Sul HS
Nat Commun; 2020 Feb; 11(1):796. PubMed ID: 32034158
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T
J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
[TBL] [Abstract][Full Text] [Related]
17. KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes.
Duan L; Rai G; Roggero C; Zhang QJ; Wei Q; Ma SH; Zhou Y; Santoyo J; Martinez ED; Xiao G; Raj GV; Jadhav A; Simeonov A; Maloney DJ; Rizo J; Hsieh JT; Liu ZP
Chem Biol; 2015 Sep; 22(9):1185-96. PubMed ID: 26364928
[TBL] [Abstract][Full Text] [Related]
18. Mutations in JMJD1C are involved in Rett syndrome and intellectual disability.
Sáez MA; Fernández-Rodríguez J; Moutinho C; Sanchez-Mut JV; Gomez A; Vidal E; Petazzi P; Szczesna K; Lopez-Serra P; Lucariello M; Lorden P; Delgado-Morales R; de la Caridad OJ; Huertas D; Gelpí JL; Orozco M; López-Doriga A; Milà M; Perez-Jurado LA; Pineda M; Armstrong J; Lázaro C; Esteller M
Genet Med; 2016 Apr; 18(4):378-85. PubMed ID: 26181491
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of miR-302 by JMJD1C inhibits neural differentiation of human embryonic stem cells.
Wang J; Park JW; Drissi H; Wang X; Xu RH
J Biol Chem; 2014 Jan; 289(4):2384-95. PubMed ID: 24318875
[TBL] [Abstract][Full Text] [Related]
20. shRNA screening identifies JMJD1C as being required for leukemia maintenance.
Sroczynska P; Cruickshank VA; Bukowski JP; Miyagi S; Bagger FO; Walfridsson J; Schuster MB; Porse B; Helin K
Blood; 2014 Mar; 123(12):1870-82. PubMed ID: 24501218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
